Skip to main content

Table 1 Maternal and neonatal outcomes

From: Esketamine combined with low-dose propofol induction strategy for category-1 cesarean section: a case series

Variable

Value

Maternal Characteristics

 

Number of patients

11

Age (years)

30.7 ± 5.8 (mean ± SD)

BMI (kg/m²)

25.3 ± 2.3 (mean ± SD)

Gestational age (weeks)

37.5 ± 2.2 (mean ± SD)

Preterm CS / Term CS

4 (36.4%) / 7 (63.6%)

Indications for CS

 

Placenta previa

1 (9.1%)

Placental abruption

1 (9.1%)

Acute fetal distress

6 (54.5%)

Umbilical cord prolapse

3 (27.3%)

Neonatal Outcomes

 

1-minute Apgar score

9 [6–10] (median [range])

5-minute Apgar score

10 (all cases)

Temporary mask ventilation

1 (9.1%)

ICU admission

0

Maternal Complications

 

Hypotension†

0

Esketamine-related adverse effects

None observed

  1. † Defined as MAP < 70 mmHg during the period from anesthesia induction to umbilical cord clamping. BMI, body mass index; CS, cesarean section; ICU, intensive care unit; MAP, mean arterial pressure